Global Tyrosine Kinase Inhibitor Market Report By Product (BCR-ABL, Tyrosine Kinase Inhibitors, Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors And Other Tyrosine Kinase Inhibitors) Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer And Others) Distribution Channel (Hospital Pharmacies, Independent Pharmacies And Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210897
May 2019
Report Formats:
As per this study the Global Tyrosine Kinase Inhibitor Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.
Tyrosine kinase inhibitor is the drug that inhibits the activity of tyrosine kinase. Tyrosine kinase plays a vital role in cell signaling, growth, and division. The tyrosine kinase inhibitor acts as a targeted therapy for the malignant tumors and functions effectively by targeting cancer cells to die causing the least damage to the normal healthy cells and thus blocks the cancer growth.
Market Dynamics
The tyrosine kinase inhibitor market is experiencing remarkable growth owing to the rise in prevalence of cancer across the globe. Rising cancer diagnosis and treatment awareness campaigns along with an increase in healthcare expenditure are driving the market growth. In addition to this, factors such as poor eating habits, excessive smoking & drinking, changing lifestyles, and genetic mutations are further boosting the cancer prevalence. This is propelling market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of tyrosine kinase inhibitor.
Market Segmentation
The broad tyrosine kinase inhibitor market has been sub-grouped into product, application and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product
- BCR-ABL, Tyrosine Kinase Inhibitors
- Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
- Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
- Other Tyrosine Kinase Inhibitors
By Application
- Chronic Myeloid Leukemia (CML)
- Lung Cancer
- Breast Cancer
- Renal Cell Cancer
- Others
By Distribution Channel
- Hospital Pharmacies
- Independent Pharmacies
- Online Pharmacies
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for tyrosine kinase inhibitor in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Tyrosine Kinase Inhibitor Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the tyrosine kinase inhibitor market include AstraZeneca Plc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eurofarma Laboratórios S/A, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis AG, and Pfizer, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Tyrosine Kinase Inhibitor
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Tyrosine Kinase Inhibitor Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY PRODUCT
- Market In BCR-ABL, Tyrosine Kinase Inhibitors
- Market In Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
- Market In Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
- Market In Other Tyrosine Kinase Inhibitors
5. TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY APPLICATION
- Market In Chronic Myeloid Leukemia (CML)
- Market In Lung Cancer
- Market In Breast Cancer
- Market In Renal Cell Cancer
- Market In Others
6. TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- Market In Hospital Pharmacies
- Market In Independent Pharmacies
- Market In Online Pharmacies
7. TYROSINE KINASE INHIBITOR MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
8. COMPETITIVE LANDSCAPE OF THE TYROSINE KINASE INHIBITOR COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
9. COMPANY PROFILES OF THE TYROSINE KINASE INHIBITOR INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- AstraZeneca Plc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- Eisai Co., Ltd.
- Eurofarma Laboratórios S/A
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Tyrosine Kinase Inhibitor
Table 2. Global Tyrosine Kinase Inhibitor Market By Product
Table 3. Global Tyrosine Kinase Inhibitor Market By Application
Table 4. Global Tyrosine Kinase Inhibitor Market By Distribution Channel
Table 5. Global Tyrosine Kinase Inhibitor Market By Geography
Table 6. North America Tyrosine Kinase Inhibitor Market
Table 7. Europe Tyrosine Kinase Inhibitor Market
Table 8. Asia Pacific Tyrosine Kinase Inhibitor Market
Table 9. Latin America Tyrosine Kinase Inhibitor Market
Table 10. Middle East And Africa Tyrosine Kinase Inhibitor Market
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Tyrosine Kinase Inhibitor Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Tyrosine Kinase Inhibitor
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Tyrosine Kinase Inhibitor Market By Product
Fig. 8. Global Tyrosine Kinase Inhibitor Market By Application
Fig. 9. Global Tyrosine Kinase Inhibitor Market By Distribution Channel
Fig. 10. Global Tyrosine Kinase Inhibitor Market By Geography
Fig. 11. North America Tyrosine Kinase Inhibitor Market
Fig. 12. Europe Tyrosine Kinase Inhibitor Market
Fig. 13. Asia Pacific Tyrosine Kinase Inhibitor Market
Fig. 14. Latin America Tyrosine Kinase Inhibitor Market
Fig. 15. Middle East And Africa Tyrosine Kinase Inhibitor Market
Fig. 16. Market Share Of Tyrosine Kinase Inhibitor Companies
Fig. 17. Recent Developments In Tyrosine Kinase Inhibitor Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
